Before the visit
Order from a link.
- Choose the battery for the question: attention (ADHD) first; cognitive change later, once that battery is built and validated.
- The patient will get a link by email or text.
For clinicians and health systems
Objective measures, ordered like a lab test.
In development. The plan: you send a link, your patient completes about 30 minutes of attention, working-memory, and processing-speed tasks at home in a web browser, and you get a structured report with validity checks, built to sit next to your interview and rating scales. ADHD first; a cognitive-decline battery with memory tasks comes later.
In developmentNot FDA clearedNot for clinical use: read our regulatory statusYou have a question that a rating scale can't answer.
A 34-year-old says focus has always been hard and is getting worse at work. A daughter says her mother keeps losing words. You have a history, a rating scale, and not much time. If you want objective performance data, there are real options: a neuropsychology referral, an FDA-cleared computerized attention test in clinic or at home, or a computerized cognitive battery. ATTNhealth is being designed to put attention and cognitive-decline testing behind one link and one report, built around how your clinic already orders and bills.
ATTNhealth's founder sees this in his own practice. He treats adults with ADHD. ATTNhealth is the assessment he wants to be able to order.
The two patients above are illustrative composites, not real cases.
From referral to report without a testing room.
The assessment
About 30 minutes, at home.
- Runs in a current web browser on a laptop or desktop. No downloads or camera.
- Plain-language instructions and practice trials before each task.
- Effort and device-timing checks are designed to run throughout.
After
A report in your queue.
- Target: within 24 hours of completion.
- Validity first, then domain scores, then the measures underneath.
- You interpret it with everything else you know about the patient.
One page to read. Every measure underneath.
The summary answers three questions. Was the session valid? How did performance compare with the reference group? Which patterns deserve a closer look?
- Session validity. Effort and engagement checks plus device timing quality. If a session can't be interpreted, the report says so first. About validity
- Domain summary. Sustained attention, response inhibition, working memory, and processing speed, each against normative comparisons once ATTNhealth norms exist. About norms
- Signal detection. d′ (how well the patient tells targets from non-targets) and criterion (how readily they respond), not just error counts. About d′
- Response-time profile. Mean and trial-to-trial variability, plus ex-Gaussian parameters that separate typical speed from occasional very slow responses. About RT
- Errors by type. Omissions (missed targets) and commissions (responses to non-targets), by task block, so you can see whether performance holds up over time. About the CPT
- Plain-language glossary. What each measure is and its known limits, so the report reads the same for a psychiatrist, a PCP, or a neuropsychologist. Known limits
Not in the report
A diagnosis, a risk score, or a probability that the patient has a condition.
Sample report · Synthetic data
Patient: Sample A · Adult · Session valid
1 Validity
- Effort checksPassed
- Device timingWithin tolerance
2 Sustained attention
d′ (target sensitivity) · omissions · commissions
3 Response-time profile
RT variability · ex-Gaussian τ (slow-response tail)
4 Normative comparison
Shown against a reference band for age
Not a diagnosis. Interpret with the full clinical picture.
What it is for. What it is not.
Designed to
- Give clinicians objective measures of attention, working memory, and processing speed
- Add performance data and a validity check to a clinical evaluation
- Track the same measures over time against a patient's own baseline, once reliable-change thresholds are established
Not designed to
- Diagnose ADHD, dementia, or any other condition
- Stand alone as the basis for a diagnosis or treatment decision
- Replace a full neuropsychological evaluation when one is needed
- Be used by patients without a clinician
Status
ATTNhealth is in development. It is not FDA cleared or approved and is not available for clinical use.
Designed around codes you already use.
ATTNhealth is being designed to fit existing CPT codes for automated psychological and neuropsychological test administration, such as 96146, and for clinician interpretation. 96146 is reported once per session, however many automated tests are given; clinician interpretation is billed separately under evaluation codes when their criteria are met. We make no claim about payment amounts. Coverage and correct coding depend on the payer, the setting, and how the test is used. Before launch, we'll publish coding guidance reviewed by a reimbursement specialist. The final call is always yours and your billing team's. During pilot and research use, nothing is billed to patients or payers.
SourceCPT code descriptions: APA Services, 2026 Testing Billing and Coding Guide
Designed for patient data, held to a higher bar before it touches any.
- This website collects only what you type into our forms. No patient health information.
- ATTNhealth collects no patient data today. When it does, it will be under an IRB-approved research protocol first.
- Built toward HIPAA requirements for the clinical product
- Built toward an independent SOC 2 Type 2 audit
- Business associate agreements with every clinical partner that shares patient data
We'll say "compliant" or "certified" only after an independent review says so.
Help build the first version in your clinic.
We're recruiting a small group of clinicians and health systems to shape the first battery, starting with ADHD, and the cognitive-decline battery that follows.
What you get
- Early access to the battery and report, starting with synthetic-data demos
- Direct input on the report, the ordering flow, and what ends up on page one
- A working line to the founder, a practicing psychiatrist
- For study sites: acknowledgment or co-authorship on publications where contribution meets authorship criteria
What we ask
- A 30-minute intro call
- Two or three feedback sessions over the pilot (about 45 minutes each)
- For study sites: enrolling patients under an IRB-approved protocol
Who it's for
- U.S. licensed clinicians who evaluate adults for attention or memory concerns: psychiatry, psychology and neuropsychology, neurology, primary care, and advanced practice clinicians
- Health systems and academic groups interested in becoming validation sites
- Adults (18+) first. Pediatric use would need its own validation study.
Timeline
Now
Applications open; intro calls.
Next
Workflow and report feedback using synthetic data.
Then
Study sites enroll once the validation protocol has IRB approval.
How data is handled
During early access, you work with synthetic data only. No patient information changes hands.
Patient data is collected only under an IRB-approved protocol, with informed consent and a signed data-use or business associate agreement.
Apply to the pilot
Six fields. A person, usually the founder, reads every application and replies within five business days.
Prefer email? Write to hello@attnhealth.com. Please don't include patient information.
What clinicians ask first.
Is ATTNhealth FDA cleared?
No. It's in development and has not been cleared or approved by the FDA. 510(k) is the planned pathway for the ADHD battery, with an FDA pre-submission meeting planned first. See our regulatory status.
Can I use it with patients today?
Not for clinical care. Before clearance, patient use will be limited to research under IRB oversight.
Does it diagnose ADHD or dementia?
No. It's designed to give you objective measures to weigh with your clinical evaluation. Diagnosis stays with you.
Is it validated?
Not yet. Validation is the next major step, and we plan to publish the results. The roadmap is on our Science page.
Isn't reaction-time variability elevated in lots of conditions?
Yes. A meta-analysis of 319 studies found adolescents and adults with ADHD were indistinguishable from other clinical groups on that measure. That's why no single number on our report is presented as a marker of ADHD, and why the report shows several measures side by side.
Does it measure hyperactivity?
No. There's no camera or motion tracking. It's designed to measure attention, response inhibition, working memory, and processing speed. That's a narrower picture than tests that track movement, and the report will say so.
Is this for memory screening?
Not yet. The first battery is for attention and ADHD evaluations in adults. A cognitive-decline battery with memory tasks comes later, with its own validation study and coding guidance. If that's your interest, apply and tell us; we'll keep you posted.
What does the patient need?
A laptop or desktop with a current web browser, a keyboard, and about 30 quiet minutes. Phone and tablet support will depend on our timing studies.
Who shouldn't take it at home?
People who can't use a keyboard, have uncorrected vision or hearing problems that affect the tasks, or need someone beside them to complete it. Those situations call for in-clinic testing. Accommodations will be studied before launch.
Where does AI come in?
Later, and narrowly. Difficulty adjustments are fixed rules, not AI. Planned models would flag disengagement for validity review and draft interpretive notes that you review, edit, and sign. They won't diagnose.
I'm a patient or parent. Can I sign up?
Not yet. ATTNhealth will be ordered by clinicians and isn't available for clinical use. We can't give medical advice. If you're concerned about attention or memory, please talk with your doctor.
Sources (2)
- American Psychological Association Services. 2026 Psychological and Neuropsychological Testing: Billing and Coding Guide. apaservices.org
- Kofler MJ, et al. Reaction time variability in ADHD: a meta-analytic review of 319 studies. Clin Psychol Rev 2013;33(6):795–811. PubMed 23872284